Search
Search Results
##search.searchResults.foundPlural##
-
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3387PDF: 1771HTML: 1170 -
-
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN ADULTS
2351PDF: 820HTML: 1305 -
FACTORS PREDICTING MORBIDITY IN PATIENTS WITH DENGUE FEVER IN A TERTIARY CARE HOSPITAL
2536HTML: 9430DOCX: 1055Tables Dengue: 250 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1914PDF: 790HTML: 523 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1333PDF: 555HTML: 23214 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3910PDF: 1556HTML: 351 -
-
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
2147PDF: 884HTML: 262 -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3822PDF: 1161HTML: 2479Figure 1: 239 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2476PDF: 1052HTML: 1668Fig 1: 226Tab I: 250Cover Letter: 247 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2909PDF: 968HTML: 305 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4721PDF: 2016HTML: 18177 -
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
261PDF: 380Suppl. Files: 74HTML: 160 -
-
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2157PDF: 1104HTML: 15737COVER LETTER: 227 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2212PDF: 896HTML: 367 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4629PDF: 3810HTML: 377 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1709PDF: 770HTML: 1466 -
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
2442PDF: 1014HTML: 11166 -
EARLY PREDICTIVE VALUE OF PERIPHERAL INFLAMMATORY INDEX COMBINED WITH HIGH-SENSITIVITY TROPONIN T FOR SEPSIS-INDUCED CARDIOMYOPATHY Inflammatory and Troponon T in cardiomyopaty from Sepsis
377PDF: 394HTML: 167 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3942PDF: 1744HTML: 11880Figures Haase: 252 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2251PDF: 1058HTML: 4103Cover Letter: 252Figure 1: 266Figure 2: 263Table 1: 245 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2804PDF: 1076HTML: 2394 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1972PDF: 1222HTML: 340 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3495PDF: 1550HTML: 4083







